CIA
CLBT icon

Concurrent Investment Advisors’s Cellebrite CLBT Stock Holding History

Concurrent Investment Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,636
Closed -$147K – 2120
2026
Q1 		$147K Buy
10,636
+326
+3% +$4.91K ﹤0.01% 1787
2025
Q4 		$186K Buy
+10,310
New +$185K ﹤0.01% 1645
2024
Q3 		– Sell
-69,849
Closed -$835K – 1106
2024
Q2 		$835K Buy
+69,849
New +$780K 0.03% 476

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Concurrent Investment Advisors's CLBT Position: Q2 2026 in Review

Concurrent Investment Advisors sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 10,636 shares — an estimated $147K sold.

Concurrent Investment Advisors first reported a position in CLBT in Q2 2024 and held it in 3 quarters. The position peaked at $835K in Q2 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Concurrent Investment Advisors reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Concurrent Investment Advisors sold 10,636 Cellebrite shares in Q2 2026, an estimated $147K.
  • Concurrent Investment Advisors first reported a position in Cellebrite in Q2 2024 and held it in 3 quarters.
  • Concurrent Investment Advisors's Cellebrite position peaked at $835K in Q2 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.